Clinical Trial Update: Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of epcoritamab in combination with Rituximab-mini CVP for newly diagnosed diffuse large B-cell lymphoma in older unfit/frail or anthracycline-inel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Epcoritamab (epcoritamab)
• Rituximab (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Large B-cell Lymphoma | Phase 2 | Status: RECRUITING